Skip to main content
. 2011 Nov 9;2011(11):CD003553. doi: 10.1002/14651858.CD003553.pub3

18.6. Analysis.

18.6

Comparison 18 Triphasic NGM 180‐215‐250 μg and EE 25 μg versus monophasic DRSP 3 mg and EE 20 μg, Outcome 6 Discontinuations due to adverse events within 3 cycles.